CN105001090A - Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate - Google Patents
Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate Download PDFInfo
- Publication number
- CN105001090A CN105001090A CN201510375901.3A CN201510375901A CN105001090A CN 105001090 A CN105001090 A CN 105001090A CN 201510375901 A CN201510375901 A CN 201510375901A CN 105001090 A CN105001090 A CN 105001090A
- Authority
- CN
- China
- Prior art keywords
- peroxide
- benzyl
- tin
- formula
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/317—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention provides a novel preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate. The intermediate is used for the synthesis of Arctigenin, and has the advantages of economical efficiency, environmental protection, efficiency and high yield.
Description
Technical field
The present invention relates to intermediate 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl used by synthesis antigout drug l-arctigenin)-but-2-ene acid methyl esters and preparation method thereof.
Background technology
At present, clinical just by (3R, 4R)-4-(3,4-the dimethoxy-benzyl)-3-(4-hydroxyl-3-methoxybenzy described in CN20108001429)-dihydrofuran compound studies as anti-pancreatic cancer cell.Clinical trial needs actual this active medicine of large-scale synthesis, and for the preparation of the intermediate of this active medicine.Therefore, need to find preparation (3R, 4R)-4-(3,4-dimethoxy-benzyl)-3-(4-hydroxyl-3-methoxybenzy) novel synthesis of-dihydrofuran.
Summary of the invention
Accordingly, the present invention relates to l-arctigenin intermediate 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters.
The present invention relates to and prepare l-arctigenin intermediate 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters novel method.
In 1-3 case study on implementation, the invention provides a kind of preparation method of formula 2 compound; Comprise:
In a heated condition, in organotin catalyzed and solvent coexisted environment, under initiator causes, formula 1 compound changes formula 2 compound into;
Wherein:
Organotin catalysts is selected from dibutyltin dilaurate, stannous octoate, two (dodecyl sulphur) dibutyl tin, dibutyltin diacetate, dioctyl tin, dialkyl tin dimaleate, two mercaptan tin alkyls, mercaptan dioctyl tin, tributyl tin, perfluoro butyl sulfonic acid tin, fluoridize in tributyltin or three (2-perfluoro hexyl) ethyl stannic hydride one or more;
Solvent is selected from one or more in ethyl acetate, toluene, benzene, methylene dichloride, DMF, DMSO, perfluoromethyl cyclohexane or acetonitrile;
Initiator is selected from organo-peroxide class: benzoyl peroxide, lauroyl peroxide, isopropyl benzene hydroperoxide, tertbutyl peroxide, di-t-butyl peroxide, dicumyl peroxide, peroxidized t-butyl perbenzoate, peroxidation trimethylacetic acid tertiary butyl ester, methylethyl ketone peroxide, cyclohexanone peroxide, di-isopropyl peroxydicarbonate, di-cyclohexylperoxy dicarbonate; Azo: one or more in Diisopropyl azodicarboxylate, 2,2'-Azobis(2,4-dimethylvaleronitrile) or azo-bis-iso-dimethyl;
Temperature of reaction is selected from one or more in 50-60 DEG C.
Embodiment 1:4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters preparation
Take (6.1 g, 10 mmol) 3-acetoxyl group-4-(3, 4-dimethoxy-phenyl)-2-(4-hydroxy-3-methoxy-benzyl)-2-nitro-3-thiophenyl-methyl-butyrate, (0.29 g, 10% mmol) tri-butyl tin hydride, (8.2 mg, 0.5% mmol) Diisopropyl azodicarboxylate adds in 250 mL there-necked flasks, with 50 mL toluene, bottleneck material is washed in bottle, stirring reaction at 50 DEG C, LC follows the tracks of reaction, react 24 h, there is the raw material of 10% unconverted, reaction solution is down to room temperature, 20 mL purified water are added in reaction solution, stir 10 min, leave standstill, separatory, which floor anhydrous sodium sulfate drying is had to be spin-dried for, through column chromatography purification enriched material, obtain yellow oil 1.5 g, yield 35%.
Embodiment 2:4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters preparation
Take (6.1 g, 10 mmol) 3-acetoxyl group-4-(3, 4-dimethoxy-phenyl)-2-(4-hydroxy-3-methoxy-benzyl)-2-nitro-3-thiophenyl-methyl-butyrate, (0.29 g, 10% mmol) tri-butyl tin hydride, add in 250 mL there-necked flasks, with 40 mL toluene, bottleneck material is washed in bottle, with 10 mL toluene by (16.4 mg, 1% mmol) Diisopropyl azodicarboxylate dissolving, in instillation reaction solution, slowly be warming up to 50 DEG C, LC follows the tracks of reaction, react 4 h, raw material is unconverted, reaction solution is down to room temperature, 20 mL purified water are added in reaction solution, stir 10 min, leave standstill, separatory, which floor anhydrous sodium sulfate drying is had to be spin-dried for, through column chromatography purification enriched material, obtain yellow oil 3.9g, yield 90%.
Embodiment 3:4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters preparation
Take (30.2 g, 50 mmol) 3-acetoxyl group-4-(3, 4-dimethoxy-phenyl)-2-(4-hydroxy-3-methoxy-benzyl)-2-nitro-3-thiophenyl-methyl-butyrate, (1.45 g, 10% mmol) tri-butyl tin hydride, add in 1000 mL there-necked flasks, with 200 mL toluene, bottleneck material is washed in bottle, with 50 mL toluene by (41.2mg, 0.5% mmol) Diisopropyl azodicarboxylate dissolving, in instillation reaction solution, slowly be warming up to 50 DEG C, LC follows the tracks of reaction, react 3 h, raw material is unconverted, reaction solution is down to room temperature, 100 mL purified water are added in reaction solution, stir 10 min, leave standstill, separatory, which floor anhydrous sodium sulfate drying is had to be spin-dried for, through column chromatography purification enriched material, obtain yellow oil 19.5 g, yield 88%.
Claims (4)
1. a l-arctigenin intermediate, is characterized in that: described l-arctigenin intermediate is the compound that general formula I represents,
In formula I:
R represents H, COR
1or R
1, wherein R
1represent C
1-18alkane;
R
2represent halogen, SR
1or OR
1, wherein R
1represent C
1-18alkane;
R
3representative, H, COR
1or R
1, wherein R
1represent C
1-18alkane.
2. l-arctigenin intermediate according to claim 1, is characterized in that: in formula I, R is H, R
2for OR
1, R
3for COR
1, R
1for CH
3,, structural formula as shown in Equation 3:
。
3. the preparation method of formula 2 compound; Comprise:
In a heated condition, in organotin catalyzed and solvent coexisted environment, under initiator causes, formula 1 compound changes formula 2 compound into;
。
4. method according to claim 3, wherein:
Organotin catalysts is selected from dibutyltin dilaurate, stannous octoate, two (dodecyl sulphur) dibutyl tin, dibutyltin diacetate, dioctyl tin, dialkyl tin dimaleate, two mercaptan tin alkyls, mercaptan dioctyl tin, tributyl tin, perfluoro butyl sulfonic acid tin, fluoridize in tributyltin or three (2-perfluoro hexyl) ethyl stannic hydride one or more;
Solvent is selected from one or more in ethyl acetate, toluene, benzene, methylene dichloride, DMF, DMSO, perfluoromethyl cyclohexane or acetonitrile;
Initiator is selected from organo-peroxide class: benzoyl peroxide, lauroyl peroxide, isopropyl benzene hydroperoxide, tertbutyl peroxide, di-t-butyl peroxide, dicumyl peroxide, peroxidized t-butyl perbenzoate, peroxidation trimethylacetic acid tertiary butyl ester, methylethyl ketone peroxide, cyclohexanone peroxide, di-isopropyl peroxydicarbonate, di-cyclohexylperoxy dicarbonate; Azo: one or more in Diisopropyl azodicarboxylate, 2,2'-Azobis(2,4-dimethylvaleronitrile) or azo-bis-iso-dimethyl;
Temperature of reaction is selected from one or more in 50-60 DEG C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510375901.3A CN105001090A (en) | 2015-07-01 | 2015-07-01 | Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510375901.3A CN105001090A (en) | 2015-07-01 | 2015-07-01 | Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105001090A true CN105001090A (en) | 2015-10-28 |
Family
ID=54374005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510375901.3A Pending CN105001090A (en) | 2015-07-01 | 2015-07-01 | Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105001090A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101104610A (en) * | 2006-07-14 | 2008-01-16 | 浙江大学 | 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof |
CN101736050A (en) * | 2009-12-08 | 2010-06-16 | 辽宁中医药大学 | Preparation method of arctigenin |
CN103145655A (en) * | 2013-01-09 | 2013-06-12 | 南京海昌中药集团有限公司 | Preparation method of high-purity arctigenin |
CN104447234A (en) * | 2014-12-08 | 2015-03-25 | 安徽万邦医药科技有限公司 | Preparation method of (3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxyl-3-methoxybenzyl)-dihydrofuran |
-
2015
- 2015-07-01 CN CN201510375901.3A patent/CN105001090A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101104610A (en) * | 2006-07-14 | 2008-01-16 | 浙江大学 | 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof |
CN101736050A (en) * | 2009-12-08 | 2010-06-16 | 辽宁中医药大学 | Preparation method of arctigenin |
CN103145655A (en) * | 2013-01-09 | 2013-06-12 | 南京海昌中药集团有限公司 | Preparation method of high-purity arctigenin |
CN104447234A (en) * | 2014-12-08 | 2015-03-25 | 安徽万邦医药科技有限公司 | Preparation method of (3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxyl-3-methoxybenzyl)-dihydrofuran |
Non-Patent Citations (1)
Title |
---|
NOBORU ONO ET AL.: "A New Synthesis of Allylic Alcohols or Their Derivatives Via Reductive Elimination from γ-phenylthio-8-nitroalcohols with Tributyltinhydride", 《TETRAHEDRON LETTERS》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103814023B (en) | The manufacture method of fluoro-3, the 4-dihydroisoquinoline derivatives of 4,4-bis- | |
CN107365297B (en) | Preparation method and intermediate of 2-methyl-2' -phenylpropionic acid derivative | |
CN102675285A (en) | Method for pure water phase preparation of rabeprazole sodium | |
CN105001090A (en) | Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate | |
CN102311457A (en) | Preparation method of rosuvastatin | |
CN102249962B (en) | Preparation method of 1,1-disulfur-1-olefin | |
CA2882138C (en) | Process for the synthesis of substituted gamma lactams | |
CN105272921A (en) | Method for preparing Ceritinib and intermediate compound of Ceritinib | |
CN107089912B (en) | Method for selectively catalyzing and synthesizing mandelate compound by metallocene complex | |
CN103755636A (en) | Method for synthesizing Lorcaserin raceme derivative | |
AU2016102188A4 (en) | Pyrazolone drug intermediates acetyl acetanilide synthesis method | |
CN104910095A (en) | Preparation method of 4-substituted-2-aminothiazole compound | |
CN102633683B (en) | Synthesis method of 1-hydroxymethyl cyclopropylacetonitrile | |
CN102838520A (en) | Amisulpride preparation method | |
CN105348278B (en) | A kind of preparation method of butanedioic acid Solifenacin impurity | |
CN105523939B (en) | A kind of preparation method of lenalidomide intermediate | |
EP3498690A1 (en) | Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as mek inhibitor | |
CN106866493B (en) | A kind of preparation method of Apremilast | |
AU2016102242A4 (en) | Busulfan drug intermediates 1, 4 - methyl sulfonic acid butyl ester synthesis method | |
CN103664716B (en) | 1-(1-virtue sulfuryl) benzyl more creates blue hydrocarbon azulenoid and preparation method thereof | |
CN103086818A (en) | Method for synthesizing alpha-oxyamide with 2-hydroxy propylene cyanide | |
WO2016043501A1 (en) | Method for preparing anhydrosugar alcohol using two-step hydrothermal reaction | |
CN102126997B (en) | Styrene monomer comprising polymerizable double bond and chain transfer sulfydryl and preparation method thereof | |
CN104447211A (en) | Intermediate compound of vitamin D drug, as well as preparation method | |
JP2012097041A (en) | Tetrahydropyrazolopyrazolone derivative having fluoroalkyl group and method of producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151028 |